FDA inspection
Orion Corporation, Orion Pharma: FDA inspection ending Jun 1, 2018
FDA inspection 1053840 · Voluntary Action Indicated (VAI) · Espoo
Key facts
| Inspection ID | 1053840 |
|---|---|
| Firm | Orion Corporation, Orion Pharma |
| FEI number | 3003073605 |
| Address | Koivu-Mankkaan Tie 6b |
| City | Espoo |
| Country | Finland |
| Fiscal year | 2018 |
| Inspection end date | Jun 1, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data